전문정보검색
| No | 제목 / 내용 |
|---|---|
| 1 |
Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, by et of to The al. and the They from have will wish with State about after await image their these author shared Benoist article conc |
| 2 |
Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, |
| 3 |
Chiral inversion of the second generation IMiD™ CC‐4047 (ACTIMID™) in human plasma and pho Abstract 10.1002/chir.10221.abs CC‐4047 is a racemic second‐generation immunomodulatory drug currently in clinical development for |
| 4 |
Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian b Polymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast c |
| 5 |
Notice of Concern: Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, by et of to The al. and the They from have will wish with State about after await image their these author shared Benoist article conc |
| 6 |
Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian b Polymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast c |
| 7 |
Sarah Czerney, Lena Eckert, Silke Martin (Hrsg.), 2020: Mutterschaft und Wissenschaft. Die (Un-) Bibliographie: Kleßen, Patricia: Sarah Czerney, Lena Eckert, Silke Martin (Hrsg.), 2020: Mutterschaft und Wissenschaft. Die (Un-)Vere |
| 8 |
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. CPX-351 and venetoclax and azacitidine (ven/aza) are both indicated as initial therapy for acute myeloid leukemia (AML) in older adult |
| 9 |
351 KEYNOTE-365 cohort D: pembrolizumab plus abiraterone acetate and prednisone in patients with ( ) + 1 2 3 4 5 D a (1 12 37 IV In NR OS PS QD an at by in mg of or to 200 AEs ALT AST CI) CR. CR; DCR For NJ, ORR OS. One PA, PSA Q3W |
| 10 |
351: Refining the identification of discriminatory genes for rejection in lung transplantation: |